Skip to content Skip to content

Press Releases


Filter Releases
 
INCLINE VILLAGE, Nev., July 28, 2010 /PRNewswire via COMTEX/ --PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today reported financial results for the second quarter ended June 30, 2010. "Our licensed products continue to generate substantial clinical interest. In early July, Roche and Genentech announced that they have filed a Biolog...
INCLINE VILLAGE, Nev., July 20, 2010 /PRNewswire via COMTEX/ --PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the Company will release its second quarter financial results on Wednesday, July 28, 2010 after the markets close. PDL's management will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss...
INCLINE VILLAGE, Nev., June 15, 2010 /PRNewswire via COMTEX/ --PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced revenue guidance for the second quarter ended June 30, 2010 of approximately $120 million, as compared with actual results of $125.9 million for the second quarter of 2009. Included in second quarter 2010 guidance is $1.5 mill...
INCLINE VILLAGE, Nev., May 4, 2010 /PRNewswire via COMTEX/ --PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the Ninth Annual JMP Securities Research Conference in San Francisco on Wednesday, May 12, 2010 at 9:00 a.m. Pacific Time. To...
INCLINE VILLAGE, Nev., April 29, 2010 /PRNewswire via COMTEX/ --PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today reported financial results for the first quarter ended March 31, 2010. Total revenues for the first quarter of 2010 were $62.1 million, compared with $62.6 million for the same period of 2009. Due to ongoing legal disputes wit...
INCLINE VILLAGE, Nev., April 22, 2010 /PRNewswire via COMTEX/ --PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the Company will hold a conference call and webcast on Thursday, April 29 at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter 2010. The call and webcast will follow the release of the first qu...
INCLINE VILLAGE, Nev., April 5, 2010 /PRNewswire via COMTEX/ --PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that it has paid the April 1, 2010 special dividend payment of $0.50 per share to all stockholders owning shares of PDL as of March 15, 2010, the Record Date. As previously announced, the conversion rate for the Compa...
INCLINE VILLAGE, Nev., March 24, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the cost basis for shares of Facet Biotech Corporation (Facet) (Nasdaq: FACT) distributed to PDL stockholders is $13.00, based on the closing price on the first day that Facet traded, December 19, 2008. On December 18, ...
INCLINE VILLAGE, Nev., March 16, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will hold its annual meeting of stockholders on Wednesday, June 9, 2010 at 9:00a.m. Pacific Time for all stockholders of record on April 15, 2010. The meeting will take place at the Hyatt Regency Hotel in Inc...
INCLINE VILLAGE, Nev., March 15, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced adjustments to the conversion rates for its 2.00% Convertible Senior Notes due February 15, 2012 (the "2012 Notes") and its 2.75% Convertible Subordinated Notes due August 16, 2023 (the "2023 Notes") effective March 16, 2010 ...
INCLINE VILLAGE, Nev., March 3, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the Cowen and Company 30th Annual Health Care Conference in Boston on Tuesday, March 9, 2010 at 1:30 p.m. Eastern Time. To acces...
INCLINE VILLAGE, Nev., March 2, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today reported financial results for the fourth quarter and full year ended December 31, 2009. Total revenues from continuing operations in 2009 were $318.2 million, an eight percent increase from $294.2 million in 2008. For the fourth qu...
INCLINE VILLAGE, Nev., Feb 22, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will hold a conference call and webcast on Tuesday, March 2 at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and full year 2009, and provide a business update. The call and web...
INCLINE VILLAGE, Nev., Feb 02, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the 12th Annual BIO CEO & Investor Conference in New York City on Monday, February 8, 2010 at 2:00 p.m. Eastern Time. To acc...
INCLINE VILLAGE, Nev., Jan 28, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that it will pay two special dividends to its stockholders in 2010. Each of the dividends will be $0.50 per share. The first special dividend will be paid on April 1, 2010 to all stockholders who own shares of PDL on March 15,...
= add release to Briefcase